Evidence map›Paper›PMID 12560454›Full record

ReviewMolecular pathology : MP2003

Molecular aspects of type 1 diabetes.

M A Kelly, M L Rayner, C H Mijovic, A H Barnett

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular pathology : MP, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Prevention of Type 1 Diabetes in Children: A Worthy Challenge?International journal of environmental research and public health · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Molecular mechanisms in autoimmune type 1 diabetes: a critical review.Clinical reviews in allergy & immunology · 2014
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.International journal of clinical and experimental pathology · 2009
    Review
  17. Review
  18. Approaches in type 1 diabetes research: A status report.International journal of diabetes in developing countries · 2009
    Article
  19. Article
  20. Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults.Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M A KellyDepartment of Medicine, Division of Medical Sciences, University of Birmingham and Birmingham Heartlands Hospital, Birmingham B9 5SS, UK. m.a.kelly@bham.ac.uk
M L Rayner
C H Mijovic
A H Barnett
Queen Elizabeth Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 diabetes is a T cell mediated autoimmune disease, characterised by the selective destruction of pancreatic beta cells, and susceptibility is determined by a combination of genetic and environmental factors. The environmental agents implicated include viruses and dietary factors, although none has yet been shown to be directly responsible for triggering beta cell autoimmunity. The genetic factors that influence disease risk have been subjected to more intensive study and two gene regions of major importance have been identified: the human leucocyte antigen locus and the insulin gene. This review will focus on the mechanisms by which these genes might influence the risk of developing type 1 diabetes.

Indexed as

Diabetes Mellitus, Type 1Disease SusceptibilityEnvironmental ExposureGenesGenes, MHC Class IGenes, MHC Class IIHLA AntigensHLA-DQ AntigensHLA-DR AntigensHumansInsulinInsulin-Like Growth Factor IILinkage DisequilibriumMajor Histocompatibility ComplexMinisatellite RepeatsPeptidesHLA AntigensHLA-DQ AntigensHLA-DR AntigensInsulinInsulin-Like Growth Factor IIPeptides

Identifiers

PMID12560454
PMCPMC1187280
OpenAlexW2113355417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.